The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats. - Wikidata - awgldk - TriplyDB

The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats.

The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats.

http://www.wikidata.org/entity/Q38336979

about

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver Fibrosis Role of redoximiRs in fibrogenesis P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy MicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4 Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis Emerging targets in lipid-based therapy MicroRNAs in metabolism and metabolic disorders Identifying miRNA-mRNA regulation network of chronic pancreatitis based on the significant functional expression The roles of microRNA families in hepatic fibrosis.Steatosis and steatohepatitis: complex disorders.Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis.miR-34 - a microRNA replacement therapy is headed to the clinic.Circulating MicroRNA Profiles Differ between Qi-Stagnation and Qi-Deficiency in Coronary Heart Disease Patients with Blood Stasis Syndrome.MicroRNA-gene expression network in murine liver during Schistosoma japonicum infection.The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesis Dynamic Expression of Novel MiRNA Candidates and MiRNA-34 Family Members in Early- to Mid-Gestational Fetal Keratinocytes Contributes to Scarless Wound Healing by Targeting the TGF-β Pathway.Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease.Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs.Role of MicroRNAs in Fibrosis.miRNA-338-3p/CDK4 signaling pathway suppressed hepatic stellate cell activation and proliferation.MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression.MicroRNA Expression Profiling in CCl₄-Induced Liver Fibrosis of Mus musculus.Familial adenomatous patients with desmoid tumours show increased expression of miR-34a in serum and high levels in tumours.miR-706 inhibits the oxidative stress-induced activation of PKCα/TAOK1 in liver fibrogenesis Genome-wide identification of novel ovarian-predominant miRNAs: new insights from the medaka (Oryzias latipes)miR-34c attenuates epithelial-mesenchymal transition and kidney fibrosis with ureteral obstruction.A new strategy for treatment of liver fibrosis: letting MicroRNAs do the job.Dual role of microRNAs in NAFLD.MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma.MicroRNAs and liver disease: viral hepatitis, liver fibrosis and hepatocellular carcinoma.The p53/miR-34 axis in development and disease.Autophagy and microRNA dysregulation in liver diseases.Delivery and targeting of miRNAs for treating liver fibrosis.Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease.MicroRNA profile analysis in the liver fibrotic tissues of chronic hepatitis B patients.MicroRNA signatures associated with thioacetamide-induced liver fibrosis in mice.MicroRNAs in hepatic pathophysiology in diabetes.MicroRNA: a connecting road between apoptosis and cholesterol metabolism.Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.

P2860

Q26768588-C5F60D1D-8DBF-4A72-97B8-735EBFF75855 Q26774309-B329E19B-DBD0-4C4F-AAE5-526952EF9A8A Q26776555-2A37F5AF-7D1F-4C1D-8967-093E10B78AD5 Q27011547-B087EBF3-2360-4362-A1F8-E8C01D15B8B2 Q28118775-FC6C5758-B5A1-484F-A53E-4EAB020FD2AE Q28237462-E236DFAF-D123-4E85-8632-F2912A7E84A0 Q28655456-69A26251-04DA-4F46-9D79-233B2E84CE0C Q33612997-D34CF787-4CA9-4BAA-A70E-2FFBBD4C531D Q33760457-C278FAEC-5796-4E3E-8B38-4220ECAA7142 Q33868794-53E2AC3E-2581-4A1C-BF9A-9307301B26C4 Q33907632-0BE0D9AD-C99D-480B-BD93-4DFFE254548D Q34169945-0AEA0DF6-69C7-4C1B-A720-EBAEC7F823C4 Q34640230-D95FF96B-74B6-4D82-A596-5FDB07FD18FB Q34753883-4358CB88-E682-4A40-9E7D-AF326930B35E Q34794616-2153189C-99A9-46D2-8A7B-BEB337A8C615 Q35055339-ADBD6113-6C83-42AA-AF3C-1273E6F772B8 Q35610932-4273A8E7-D8EA-44B5-9DDB-D38025C99AC2 Q36018329-AD4711D9-8141-42BA-815B-1BDDD75214B1 Q36069681-E27F7462-33F1-4B53-ACF3-5A39944BFBBD Q36093326-7DB36A3F-DB44-47AB-949C-1970C9A3D4AC Q36251701-02C7CDEE-F820-4B43-9F36-CF3ED8D6C778 Q36719130-112BDDAA-DAA6-49EE-8455-4E7AC75AB2EE Q37050843-A30F6160-2161-4033-9CFB-47A26DE4F964 Q37136293-AB116723-689F-4F46-A59B-CB37A6AEC4B8 Q37431181-3A36B355-357D-42FD-9D86-AAF2C915F4ED Q37575841-D75D1306-ABF6-49AB-86E1-D3C3383BCA7C Q37681848-4D7358BD-F7A9-426D-85FE-4E4F7765C8E7 Q38074884-DA47C6CE-FAB8-4D2D-B2AE-1F8865FD86F7 Q38099737-C07E1356-56D9-479C-9754-6277EF77AA80 Q38139865-E42006A3-3FC6-40D2-A352-71216A165B92 Q38163522-E4B3BB6D-3C0E-4922-9CEF-298A614DC660 Q38210767-B85F454E-A29E-4CCD-86E5-2C6C25FAE1E9 Q38228503-FD7B21A7-338A-4448-B6AD-35E1A960DF31 Q38245905-FA01A407-1945-458B-932A-899D20CC693D Q38246145-6F8BA861-4818-4E53-B802-581590BF65ED Q38437666-B84969D2-62BA-44FF-9954-2E0ECBF42DA3 Q38709130-70508D22-EC8A-4D76-8B1A-B971BC59E9C7 Q38751634-C85D314A-8FE6-4316-818E-BC226E46DFE9 Q38815056-7005ED68-14BD-4634-8F6C-CB6FB5C722F0 Q38858897-1B341BA5-B586-4682-AF68-E70E05FA0FB5

P2860

The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats.

http://www.wikidata.org/entity/Q38336979

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

The rno-miR-34 family is upreg ...... uced hepatic fibrosis in rats.

@en

type

label

The rno-miR-34 family is upreg ...... uced hepatic fibrosis in rats.

@en

prefLabel

The rno-miR-34 family is upreg ...... uced hepatic fibrosis in rats.

@en

P1433

Q38336979-A2F32BE7-CDF2-4CD2-8D22-C04A7B2DA8E3

P1476

Q38336979-8413665E-3739-4F22-B795-2126CD5EE4E6

P2093

Q38336979-083B3EF8-4A38-433B-BA46-AE80CD50865D

Q38336979-0A655648-91F3-4511-A4A1-40AD9482C9E9

Q38336979-2BB88CC5-37F7-4B30-AD46-7308C69AD0DD

Q38336979-5085C87F-6CB9-48CE-8AF1-0C477A795164

Q38336979-79729949-018E-4A6E-A918-A4D4B61CA001

Q38336979-7EB33D75-5ED6-4D25-8FD3-EA4D1829C8BD

Q38336979-8E5D0893-ED3F-4680-8012-F6B285D9EC7F

Q38336979-A8B94BFC-6D45-455F-8A42-95BFDE3E0CA0

Q38336979-D650720A-6DC6-44E0-AE50-69FD8783CEA9

Q38336979-D6D19E39-5E6F-4F1B-94FC-96B55F935C50

P2860

Q38336979-0280F57B-D4FC-4E33-8937-7CC4809DCA13

Q38336979-0F28C6FD-9997-4BFD-B0C5-D8D08278AE28

Q38336979-11BE70C9-929C-42ED-B0FA-542B8E5C0C7E

Q38336979-12674B4C-D98E-4726-8E84-DEE3F898F913

Q38336979-18E1FB61-C37A-4647-AA3A-C0C5EC16DB15

Q38336979-19527AB3-1DC9-4732-AD14-6714DC4E6FAA

Q38336979-1C20E87E-D2FC-4381-929E-192730A4F866

Q38336979-1C7DAD1E-F01A-4AB2-B7D0-EB3F9F9E2E57

Q38336979-231CE608-C315-4065-856C-3ED62D73B875

Q38336979-244BFDB9-5E3D-4917-95A2-EF62CDA49DF6

P304

Q38336979-61761423-6367-42AF-8102-AEEEB90116B2

P31

Q38336979-93343B99-F964-4A45-A6F9-F8942485F393

P356

Q38336979-D4575355-5071-42F4-9FE8-0DC4CE3CEEF3

P407

Q38336979-07FCBB2B-2E4A-44AB-80D9-9AD82FCE27BB

P433

Q38336979-F58B0A44-0D8A-4E93-B439-21ECC4F3CFDE

P478

Q38336979-00920061-8845-44DA-96E7-87FFDF870043

P577

Q38336979-8ADEECA5-3229-4C85-8E90-A2BE95DB3C4F

P5875

Q38336979-63201632-BBB9-44FE-835A-6B0CDA60F0C6

P698

Q38336979-BCB330A4-2AEA-40F1-8DA3-F3E11DD9654A

P356

J.1742-4658.2011.08075.X

P1433

P1476

The rno-miR-34 family is upreg ...... uced hepatic fibrosis in rats.

@en

P2093

Chao Chen

http://www.w3.org/2001/XMLSchema#string

Hong-Yu Yu

http://www.w3.org/2001/XMLSchema#string

Hui-Min Liu

http://www.w3.org/2001/XMLSchema#string

Jia Guo

http://www.w3.org/2001/XMLSchema#string

Jin He

http://www.w3.org/2001/XMLSchema#string

Liang Zhu

http://www.w3.org/2001/XMLSchema#string

Mi-Die Xu

http://www.w3.org/2001/XMLSchema#string

Qing-Mei Xia

http://www.w3.org/2001/XMLSchema#string

Wei-Qing Li

http://www.w3.org/2001/XMLSchema#string

Yi-Ming Li

http://www.w3.org/2001/XMLSchema#string

P2860

Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Emerging role of microRNAs in liver diseases

MicroRNAs: genomics, biogenesis, mechanism, and function

Suppression of type I collagen production by microRNA-29b in cultured human stellate cells

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets

A microRNA component of the p53 tumour suppressor network

P304

1522-1532

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1742-4658.2011.08075.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

278

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50265883

http://www.w3.org/2001/XMLSchema#string

P698

21366874

http://www.w3.org/2001/XMLSchema#string